Form 4: Innoviva CFO Stephen Basso Reports Stock Transactions

Innoviva, Inc. CFO Stephen Basso acquired shares via an employee plan and disposed of shares to cover tax obligations.

Summary

• Stephen Basso, Chief Financial Officer of Innoviva, Inc., acquired 1,123 shares of common stock on May 15, 2026, through the company's Employee Stock Purchase Plan.
• On May 20, 2026, 559 shares were withheld by the company to satisfy tax withholding obligations related to the vesting of equity grants.
• Following these transactions, the reporting person holds a total of 88,571 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine disclosure of executive equity transactions with no material impact on company outlook.

Positives

• The acquisition of shares through the Employee Stock Purchase Plan indicates continued alignment between the CFO and company equity performance.

Negatives

• The disposal of 559 shares was a mandatory tax withholding event, not a voluntary sale.

Risks

• None identified in this filing.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that this is a routine administrative filing regarding executive compensation and tax compliance, typical for publicly traded companies, and does not signal a change in corporate strategy or financial health.

Comparison to Industry Standards

• The use of share withholding to satisfy tax obligations upon vesting is a standard practice for executive compensation in the biotechnology and pharmaceutical sectors.

Stakeholder Impact

• Minimal impact on shareholders as these are standard executive compensation adjustments.

Key Dates

Keywords

Innoviva, INVA, Form 4, Insider Trading, CFO, Equity Compensation